REFERENCES
- Mauser-Bunschoten E P, Van der Bom J G, Bongers M. Purity of factor VIII product and incidence of inhibitors in previously untreated patients with haemophilia A. Haemophilia. 2001; 7: 364–368, [PUBMED], [INFOTRIEVE], [CSA]
- Di Michele D. Inhibitors: resolving diagnostic and therapeutic dilemmas. Haemophilia. 2002; 8: 280–287, [CSA], [CROSSREF]
- Wight J, Paisley S. The epidemiology of inhibitors in haemophilia A: a systematic review. Haemophilia. 2003; 9: 418–435, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Van d er, Bom J G, Mauser-Bunschoten E P, Fischer K, Van den Berg H M. Age at first treatment and immune tolerance to factor VIII in severe hemophilia. Thromb Haemost. 2003; 89: 475–479, [CSA]
- Aledort L M. Unsolved problems in haemophilia. Haemophilia. 1998; 4: 341–345, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hoyer L W. The incidence of factor VIII inhibitors in patients with severe hemophilia A. Adv Exp Med Biol. 1995; 386: 35–45, [PUBMED], [INFOTRIEVE], [CSA]
- Oldenburg J, Brackmann H H, Schwaab R. Risk factors for inhibitor development in hemophilia A. Haematologica. 2000; 85: 7–13, suppl[PUBMED], [INFOTRIEVE], [CSA]
- Lorenzo J I, Lopez A, Altisent C, Aznar J A. Incidence of factor VIII inhibitors in severe haemophilia: the importance of patient age. Br J Haematol. 2001; 113: 600–603, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Knobe K E, Tengborn L I, Petrini P, Ljung R CR. Breastfeeding does not influence the development of inhibitors in haemophilia. Haemophilia. 2002; 8: 657–659, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kasper C K, Aledort L M, Counts R B. A more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh. 1975; 34: 869–872, [CSA]
- Verbruggen B, Novakova I, Wessels H, Boezeman J, Van den Berg H M, Mauser-Bunschoten E P. The Nijmegen modification of the Bethesda assay for factor VIII:C inhibitors: improved specificity and reliability. Thromb Haemost 1995; 73: 247–251, [PUBMED], [INFOTRIEVE], [CSA]
- Mauser-Bunschoten E P, Rosendaal F R, Nieuwenhuis H K, Roosendaal G, Briet E, Van den Berg H M. Clinical course of factor VIII inhibitors developed after exposure to a pasteurised Dutch concentrate compared to classic inhibitors in hemophilia A. Thromb Haemost. 1994; 71: 703–706, [PUBMED], [INFOTRIEVE], [CSA]
- Bulk-Bunschoten A MW, Pasker-De Jong P CM, Van Bodegom S, Reerink J D, De Groot C J. Breast- and formula feeding during the first four months of life in 4438 infants. Ned Tijdschr Geneesk. 2002; 146: 2028–2033, [CSA]
- Bland R M, Rollins N C, Solarsh C, Van den Broeck J, Coovadia H M. Maternal recall of exclusive breastfeeding duration. Arch Dis Child. 2003; 88: 778–783, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kaplan J, Genyea C, Secord E. Factor VIII inhibitors: potential for prevention of inhibitor formation by immune tolerance. Semin Thromb Hemost. 2000; 26: 173–178, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hanson L A. Breastfeeding provides passive and likely long-lasting active immunity. Ann Allergy Asthma Immunol. 1998; 81: 523–533, [PUBMED], [INFOTRIEVE], [CSA]
- Larocca D, Peterson J A, Urrea R, Kuniyoshi J, Bistrain A M, Ceriani R L. A Mr 46,000 human milk fat globule protein that is highly expressed in human breast tumors contains factor VIII-like domains. Cancer Res. 1991; 51: 4994–4998, [PUBMED], [INFOTRIEVE], [CSA]
- Yee T T, Lee C A. Oral immune tolerance induction to factor VIII via breast milk, a possibility?. Haemophilia. 2000; 6: 591, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]